These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32192603)

  • 41. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trend in the incidence of smear-positive tuberculosis in a district in South India after DOTS implementation.
    Subramani R; Gomathy S; Lakshmi M; Swaminathan S
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1022-6. PubMed ID: 27393534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Community vs. facility-based directly observed treatment for tuberculosis in Tanzania's Kilimanjaro Region.
    van den Boogaard J; Lyimo R; Irongo CF; Boeree MJ; Schaalma H; Aarnoutse RE; Kibiki GS
    Int J Tuberc Lung Dis; 2009 Dec; 13(12):1524-9. PubMed ID: 19919771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Smear Conversion, Treatment Outcomes and the Time of Default in Registered Tuberculosis Patients on RNTCP DOTS in Puducherry, Southern India.
    Vasudevan K; Jayakumar N; Gnanasekaran D
    J Clin Diagn Res; 2014 Oct; 8(10):JC05-8. PubMed ID: 25478371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relapse after short-course chemotherapy of patients with sputum smear-positive pulmonary tuberculosis under routine conditions with additional information on side effects and contact tracing.
    Martinez FD; Hernandez HM
    Tuber Lung Dis; 1996 Oct; 77(5):425-8. PubMed ID: 8959146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coping with tuberculosis and directly observed treatment: a qualitative study among patients from South India.
    Yellappa V; Lefèvre P; Battaglioli T; Narayanan D; Van der Stuyft P
    BMC Health Serv Res; 2016 Jul; 16():283. PubMed ID: 27430557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of patient's experiences with daily DOTS.
    Moorthy A; Jaggi S; Garg K; Kaur Sodhi M; Aggarwal D; Chander J
    Indian J Tuberc; 2022 Oct; 69(4):453-459. PubMed ID: 36460375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug susceptibility pattern of Mycobacterium tuberculosis isolates from patients of category-II failure of pulmonary tuberculosis under directly observed treatment short-course from north India.
    Prasad R; Verma SK; Garg R; Jain A; Anand SC; Hosmane GB; Verma RK; Kushwaha NS; Kant S
    Biosci Trends; 2012 Jun; 6(3):110-4. PubMed ID: 22890158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IMA GFATM RNTCP PPM project: milestones in sight one year after.
    Chugh S
    J Indian Med Assoc; 2008 Jul; 106(7):454-8. PubMed ID: 18975501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar.
    Al-Shaer MH; Mansour H; Elewa H; Salameh P; Iqbal F
    BMC Infect Dis; 2017 Feb; 17(1):118. PubMed ID: 28152986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment practices in pulmonary tuberculosis by private sector physicians of Meerut, Uttar Pradesh.
    Yadav A; Garg SK; Chopra H; Bajpai SK; Bano T; Jain S; Kumar A
    Indian J Chest Dis Allied Sci; 2012; 54(3):161-3. PubMed ID: 23008922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of treatment outcome in re-treatment versus new smear positive cases of tuberculosis under RNTCP.
    Pardeshi GS; Deshmukh D
    Indian J Public Health; 2007; 51(4):237-9. PubMed ID: 18232166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of shortened directly observed treatment on compliance and cure rate of pulmonary tuberculosis].
    Martínez-Medina MA
    Gac Med Mex; 2004; 140(1):1-6. PubMed ID: 15022881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are registered sputum smear-negative tuberculosis patients in Karnataka, India, diagnosed by national algorithm?
    Chadha VK; Praseeja P; Hemanthkumar NK; Shivshankara BA; Sharada MA; Nagendra N; Padmesh R; Puttuswamy G; Ahmed J; Kumar P
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1491-5. PubMed ID: 25517817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi.
    Myneedu VP; Singhal R; Khayyam KU; Sharma PP; Bhalla M; Behera D; Sarin R
    J Epidemiol Glob Health; 2015 Dec; 5(4):365-73. PubMed ID: 25944154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Revised national TB control programme in India.
    Chauhan LS; Tonsing J
    Tuberculosis (Edinb); 2005; 85(5-6):271-6. PubMed ID: 16253562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Twice-weekly intermittent chemotherapy during the maintenance phase of the short-course treatment for new patients with pulmonary tuberculosis].
    Wada M; Mizoguchi K; Okumura M; Mitarai S; Hoshino H; Ohmori M; Uchimura K; Yoshiyama T; Ogata H
    Kekkaku; 2006 May; 81(5):363-9. PubMed ID: 16768170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of isoniazid-resistant tuberculosis in southeastern Texas.
    Escalante P; Graviss EA; Griffith DE; Musser JM; Awe RJ
    Chest; 2001 Jun; 119(6):1730-6. PubMed ID: 11399698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA; Ismailov ShSh; Berikova EM
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.